News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
375,689 Results
Type
Article (25713)
Company Profile (70)
Press Release (349906)
Section
Business (104183)
Career Advice (446)
Deals (16863)
Drug Delivery (47)
Drug Development (47508)
Employer Resources (47)
FDA (12228)
Job Trends (8418)
News (185721)
Policy (19386)
Tag
Academia (1730)
Alliances (26595)
Alzheimer's disease (731)
Approvals (12217)
Artificial intelligence (99)
Bankruptcy (136)
Best Places to Work (6862)
Breast cancer (131)
Cancer (879)
Cardiovascular disease (78)
Career advice (407)
Cell therapy (142)
Clinical research (39654)
Collaboration (265)
Compensation (62)
COVID-19 (1456)
C-suite (64)
Data (954)
Diabetes (108)
Diagnostics (3384)
Earnings (36055)
Events (50726)
Executive appointments (247)
FDA (12755)
Funding (227)
Gene therapy (77)
GLP-1 (328)
Government (2996)
Healthcare (12137)
Infectious disease (1507)
Inflammatory bowel disease (67)
IPO (6981)
Job creations (1836)
Job search strategy (377)
Layoffs (153)
Legal (3616)
Lung cancer (146)
Lymphoma (63)
Manufacturing (74)
Medical device (12736)
Medtech (12739)
Mergers & acquisitions (9993)
Metabolic disorders (286)
Neuroscience (926)
NextGen Class of 2024 (3926)
Non-profit (2815)
Northern California (873)
Obesity (165)
Opinion (63)
Parkinson's disease (56)
Patents (60)
People (34202)
Phase I (11347)
Phase II (17175)
Phase III (14101)
Pipeline (291)
Postmarket research (1667)
Preclinical (3539)
Radiopharmaceuticals (156)
Rare diseases (120)
Real estate (2838)
Regulatory (13770)
Research institute (1598)
Southern California (756)
Startups (2116)
United States (8457)
Vaccines (297)
Weight loss (114)
Date
Today (1)
Last 7 days (335)
Last 30 days (1352)
Last 365 days (19807)
2024 (19716)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32196)
2019 (28415)
2018 (21811)
2017 (18906)
2016 (18111)
2015 (21195)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (353)
Arizona (92)
Asia (24144)
Australia (3817)
California (1928)
Canada (877)
China (214)
Colorado (108)
Connecticut (114)
Delaware (66)
Europe (47091)
Florida (329)
Georgia (84)
Illinois (260)
Indiana (157)
Japan (56)
Kansas (67)
Maryland (455)
Massachusetts (1403)
Michigan (77)
Minnesota (194)
New Jersey (710)
New York (592)
North Carolina (422)
Northern California (873)
Ohio (92)
Pennsylvania (570)
South America (518)
Southern California (756)
Texas (327)
Utah (63)
Washington State (159)
375,689 Results for "sequana medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Press Release: Sequana Medical announces update on second tranche of convertible bridge loan
December 2, 2024
·
4 min read
Press Releases
Press Release: Sequana Medical announces Extraordinary General Meeting of Shareholders on 20 December 2024
November 20, 2024
·
4 min read
Press Releases
Press Release: Sequana Medical Announces New Share Capital Amount and New Number of Shares
November 15, 2024
·
7 min read
Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024
Sequana Medical NV announces data from its North American pivotal POSEIDON study of the alfapump® demonstrating significantly improved quality of life focused on ascites symptoms and physical functions compared to baseline, which is not seen in refractory ascites patients enrolled contemporaneously in the prospective NACSELD3 cohort.
June 6, 2024
·
8 min read
Press Releases
Press Release: Publication in Kidney Medicine Highlights Benefits of DSR 2.0 for Sequana Medical’s Direct Sodium Removal Heart Failure Program and Board Composition Update
November 27, 2024
·
8 min read
Press Releases
Sequana Medical announces H1 2024 results and provides business update
October 1, 2024
·
20 min read
Policy
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces the agreed outcome of the “Day 100” meetingi with the US Food and Drug Administration, following receipt of the “Day 90” major deficiency Letter.
May 22, 2024
·
8 min read
Business
Sequana Medical announces 2023 Full Year Results and 2024 Outlook
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces its financial results for the year ended 31 December 2023, and provides a business update and outlook for 2024 and beyond.
March 28, 2024
·
21 min read
Press Releases
Press Release: Sequana Medical Announces Strong 24-Month Results from POSEIDON Study at AASLD The Liver Meeting® in San Diego; US PMA alfapump approval expected before end of Q1 2025
November 18, 2024
·
10 min read
Sequana Medical granted US CPT® III reimbursement codes for alfapump® system
Sequana Medical NV announces that the American Medical Association has issued six new Category III Current Procedural Terminology codes for the alfapump system, an important step in facilitating reimbursement for the Company’s innovative medical device for the treatment of recurrent or refractory ascites due to liver cirrhosis.
January 3, 2024
·
7 min read
1 of 37,569
Next
